AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
LEXINGTON, Mass.--(BUSINESS WIRE)-- AMAG Pharmaceuticals, Inc. (AMAG) (NASDAQ: AMAG) today announced that William Heiden, AMAGs new chief executive officer, will present at two investor conferences in June. The presentations will include a company overview and a review of the companys growth opportunities.
The presentations will take place as follows:
- June 4, at 9:30 a.m. EDT Jefferies 2012 Global Healthcare Conference in New York City; and
- June 6, at 2:40 p.m. PDT Goldman Sachs 33rd Annual Global Healthcare Conference in Rancho Palos Verdes, California.
A live webcast of each presentation will be accessible through the Investors section of the companys website at www.amagpharma.com. Following the conferences, the webcasts will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303
Source: AMAG Pharmaceuticals, Inc.Copyright Business Wire 2012